LPs Want Metrics. Founders Want Systems. Most Funds Have Neither.
You are caught between LPs demanding proof of value-add and founders comparing offers. Vague platform claims no longer differentiate. AEIOU gives you measurable operational infrastructure - so you stop competing on price and start competing on value.
Every fund promises operational support. Few can prove they delivered it.
You have heard this before. Every platform claims to add value. We built AEIOU to be measurable from day one - because we knew you would need to see the data.
3 minutes. No commitment. See exactly where your portfolio stands.
You Tell LPs You Add Value. You Tell Founders You Are Hands-On. Can You Prove It?
Every fund pitch deck promises value beyond capital. But when LPs ask for metrics - or when founders compare your offer to another - what do you actually show them?
The Industry's Uncomfortable Truth
75% of VC-backed startups fail to return capital. But here is the question nobody asks: how many of those failures were preventable?
These are not cosmetic problems. They are exit-friction multipliers - issues that block follow-on financing, delay regulatory progress, and discount value at M&A.
The Squeeze You Are Feeling
From LPs: "What are you doing beyond picking? Show us the systems. Show us the metrics."
From Founders: "Their offer includes structured support. Yours does not."
The Game Is Changing. The Funds That Adapt Will Win.
Three forces are reshaping how funds compete.
LP Scrutiny Is Intensifying
LPs are no longer satisfied with stories. They want portfolio-level metrics on value-add.
Founder Optionality Is at All-Time Highs
The best founders have multiple term sheets. Structured support is becoming a deciding factor.
Platform Claims Have Become Noise
Everyone claims to be "hands-on." The bar has moved to proof.
Not All Problems Are Equal. Some Kill Deals.
Our diagnostic surfaces issues by VC impact.
Deal-Killers
Issues that stop financings and kill acquisitions
- Cap table confusion / securities compliance gaps
- IP chain-of-title issues
- Governance dysfunction preventing decisions
Value Destroyers
Issues that drive down price and worsen terms
- Leadership instability / team gaps
- Not diligence-ready
- Documentation gaps requiring remediation
Performance Killers
Issues that show up as failures downstream
- Strategy incoherence
- Risk oversight gaps
- Board/management misalignment
Our diagnostic identifies which tier your portfolio companies fall into.
Take the Portfolio DiagnosticOne Board Request. Everything Unraveled.
A Series B company. $25 million raised. Breakthrough technology. Preparing to raise their Series C.
Then a board investor requested cap table diligence. The company could not produce it.
"On ice, the spin is never a surprise. It is simply the bill coming due for decisions made earlier."
This company is hiding in your portfolio.
How Exit-Ready Is Your Portfolio?
Take the 3-Minute Assessment
10 questions. Instant results. See exactly where your portfolio stands across five critical dimensions.
Operational Excellence - Defined, Measured, Tracked
For the first time, portfolio support becomes as measurable as financial performance.
Governance Hygiene
Board cadence, documentation, decision logs, fiduciary compliance
Documentation Readiness
Data room completeness, contract organization, cap table accuracy
Structural Literacy
Term sheet comprehension, protective provisions, dilution math
Exit Readiness
Due diligence preparation, negotiation capability, stakeholder alignment
See where your portfolio stands in 3 minutes.
Take the Portfolio DiagnosticOperational Infrastructure - Not Advice
We install systems - measurable, deployable, LP-reportable.
Structured Capability Building
7 courses covering operational fundamentals. Built by a founder who led a $5.75B exit.
50+ Board-Ready Artifacts
Actual documents your portfolio companies deploy immediately.
Ongoing Monitoring
Like pilots, founders recertify annually. You catch drift before crisis.
LP-Ready Reporting
Everything we measure feeds into dashboards you can show LPs.
Operator Insight. Educator Architecture.
A founder who led a $5.75B exit and an educator who makes knowledge stick.
Christos holds a DBA and JD and was selected by the UAE Prime Minister's Office as a Stanford Innovation Fellow. He is a Fulbright Specialist with 15+ years developing founders and advising across four continents. He has taught at top institutions globally and holds eight advanced degrees.
He is leading the research methodology behind the Portfolio Health Benchmark Study - building the data that will define operational excellence for funds.
Chris spent 13 years as a GP and has sat on both sides of the table - as founder, investor, and board director. He founded Auris Health and led it to a $5.75 billion exit to Johnson and Johnson, the largest acquisition of a venture-backed medical device company on record. He holds the NACD Directorship Certification and has negotiated over $9 billion in M&A transactions.
He personally reviews every assessment in the research study and leads conversations with participating funds about their results.
Teaching & Speaking Around the World
Differentiate on Value - Not Price
AEIOU makes you more competitive on both ends of the squeeze.
Win LP Allocations
Walk into LP meetings with portfolio-level operational metrics. You have data, not stories.
Win Competitive Deals
When founders compare offers, yours includes structured operational support.
Multiply Your Time
We handle operational infrastructure so you do not have to build it yourself.
Three Steps. Zero Ambiguity.
Simple to deploy. Clear to measure. Easy to explain to LPs and founders.
Assess
We diagnose operational health across your portfolio.
Deploy
We install the systems - capability building, artifacts, frameworks.
Report
You get ongoing measurement and LP-ready reporting.
Not Intuition. Research.
We built AEIOU on evidence, not hope.
What the Research Shows
Accelerator studies provide evidence that structured support materially improves venture outcomes.
"Entrepreneurship schooling bundled with services can significantly increase venture performance."
Gonzalez-Uribe & Leatherbee, Review of Financial Studies, 2018"Accelerator participation shows positive effects on funding milestones and outcomes."
Assenova & Amit, Strategic Management Journal, 2024How We Prove It Works
We built measurement into every layer.
- ✓Baseline diagnostic before any intervention
- ✓Leading indicators tracked throughout
- ✓Progress visible at company and portfolio level
- ✓LP-ready reporting with actual metrics
What GPs Ask Us
Straight answers to the questions we hear most often.
"Does this actually improve outcomes, or is it just box-checking?"
Research shows structured support materially improves outcomes - when it includes capability building, not just services. We measure leading indicators so you can see progress, and we track outcomes so you can correlate. We built this to be provable, not just deliverable.
"Our founders are too busy for this."
That is backwards. Your founders are too busy because they are learning operational basics through trial and error - reinventing what is already known while also building a company. A genius engineering team should iterate the product, not the systems to run the company. Every hour a technical founder spends figuring out "how does a board actually work?" is an hour not spent on what only they can do. We compressed 30 years into 14 weeks. The question is not whether they have time. It is whether they can afford to keep wasting time on solved problems.
"How is this different from what our platform team does?"
Your platform team is probably covering 30 companies with 2 people. They are stretched thin. You are already promising founders "intros to world-class practitioners" and "operational support" - AEIOU is how you systematize that promise and prove to LPs you delivered. We are not replacing your platform team - we are multiplying their capacity. We install the systems; they provide the judgment and relationships.
"What does this cost?"
Fund partnerships start at $120K annually for portfolio-wide access. But we do not discuss pricing until after the diagnostic - because we want you to see the value before we talk numbers. Take the assessment first.
Portfolio Health Benchmark Study
Help Define the Standard. Get the Data First.
We are building the first empirical benchmark for portfolio operational health - the data that will define what "good" looks like for VC and PE funds. Participating funds get early access to the findings and direct input into the research methodology.
The Value Exchange
Your Portfolio Assessment
Complete the full diagnostic across your portfolio. We aggregate anonymized data to build industry benchmarks.
Early Access to Findings
Receive the benchmark report before public release. See how your portfolio compares to peers across all dimensions.
Shape the Methodology
Join the research advisory group. Your input helps define which metrics matter most for predicting exit success.
This is a research partnership, not a sales conversation. We are genuinely building something new and want the right funds involved from the start.
Ready to participate?
Start with the Portfolio Diagnostic to see your baseline, then register for the Full Assessment to receive the complete analysis.
We Are Selecting 5 Funds for Our Founding Cohort
In 5 years, every top-quartile fund will have operational infrastructure like this. The question is whether you are building it now or catching up later. We are looking for funds that want to lead - not follow.
Founding cohort applications close Q1 2026. Limited to 5 funds.
